Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.2
Consolidated Balance Sheets - USD ($)
Apr. 30, 2021
Apr. 30, 2020
Current Assets    
Cash $ 277,347 $ 236,668
Accounts Receivable, net 321,693
Inventory 362,072 78,650
Other 678,898 3,020
Total Current Assets 1,640,010 318,338
Goodwill 8,017,333 2,466,073
Intangible assets, net 2,032,169 20,000
Other 3,853 3,853
TOTAL ASSETS 11,693,365 2,808,264
Current Liabilities    
Accounts payable 541,903 249,050
Accrued expenses 614,050 89,342
Notes payable 269,045 118,771
Note payable to related party 390,209 333,684
Customer deposits 46,096 38,419
Warrant derivative liability 2,812,767
Total Current Liabilities 4,674,070 829,266
Convertible debentures, net 450,000
Due to related party 1,753,000
Total Long Term Liabilities 1,753,000 450,000
Commitments and contingencies
Stockholders' Equity    
Series A Preferred Stock - shares authorized 2,200,000; outstanding 158,704 and 208,704; Series B Preferred Stock - shares authorized 4,300,000; outstanding 1,968,676 and 3,681,623 21,274 38,903
Common stock - shares authorized 500,000,000; outstanding 29,431,264 and 20,011,091 29,431 20,011
Additional paid-in capital 21,025,518 4,043,837
Accumulated deficit (15,809,928) (2,573,753)
Total Stockholders' Equity 5,266,295 1,528,998
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 11,693,365 $ 2,808,264